Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Committee To Review WHO's Antimalarial Drug

This article was originally published in The Pink Sheet Daily

Executive Summary

The World Health Organization is seeking approval of artesunate rectal suppositories as an initial treatment for those living in remote locations.

You may also be interested in...



WHO Closer To FDA Approval For Malaria Drug

FDA has been holding the world body to the same standards it uses for a regular drug review, resulting in many years of delay in bringing artesunate rectal suppositories to market - but the Anti-Infective Drugs Advisory Committee has given a partial endorsement.

WHO Closer To FDA Approval For Malaria Drug

FDA has been holding the world body to the same standards it uses for a regular drug review, resulting in many years of delay in bringing artesunate rectal suppositories to market - but the Anti-Infective Drugs Advisory Committee has given a partial endorsement.

WHO's Malaria Drug Gets A Second Chance At Advisory Committee

The World Health Organization is hoping advisory committee approval of its artesunate rectal suppositories to treat malaria will help it overcome a long and rocky regulatory path with FDA.

Related Content

Topics

UsernamePublicRestriction

Register

PS070485

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel